Literature DB >> 20966044

Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes.

Ikumi Washio1, Makiko Maeda, Chika Sugiura, Ryota Shiga, Mitsuhiro Yoshida, Shinpei Nonen, Yasushi Fujio, Junichi Azuma.   

Abstract

Smoking induces a wide range of drug-metabolizing enzymes. Among them, CYP2B6 as well as CYP1A2 is well known to be up-regulated in smokers. Although the induction of CYP1A2 is mediated by the aryl hydrocarbon receptor, the molecular mechanisms of CYP2B6 induction by smoking remain to be fully elucidated. In this study, by preparing cigarette smoke extract (CSE), we addressed the possibility that human constitutive androstane receptor (hCAR) is involved in smoking-mediated induction of CYP2B6. In HepG2 cells, CSE induced CYP1A2 but not CYP2B6, suggesting that CYP2B6 expression is differentially regulated from CYP1A2. Compared with liver in vivo, hCAR expression is dramatically reduced in cultured hepatocytes, such as HepG2. Therefore, to reconstitute hCAR signaling pathways in vitro, we generated adenovirus vector expressing hCAR. Real-time reverse transcription-polymerase chain reaction analyses revealed that the adenoviral transfection of hCAR resulted in the up-regulation of CYP2B6 mRNA, even in the absence of CSE. It is interesting to note that CSE stimulation augmented hCAR-mediated induction of CYP2B6. In contrast, the expression of CYP2B6 was not enhanced by adenovirus vector expressing β-galactosidase, a control vector, either in the presence or absence of CSE. In summary, hCAR mediated the CYP2B6 induction by CSE in Hep2G cells. These data suggest that smoking up-regulates CYP2B6 through hCAR in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20966044     DOI: 10.1124/dmd.110.034504

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  12 in total

Review 1.  Cigarette smoking and clopidogrel interaction.

Authors:  Kristopher J Swiger; Omair Yousuf; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

2.  Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery disease.

Authors:  Jung Rae Cho; Bhaloo Desai; Michael J Haas; Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Antonio Tello-Montoliu; Elisabetta Ferrante; Luis A Guzman; Theodore A Bass; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-12-20       Impact factor: 4.132

3.  Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study.

Authors:  Fabiana Rollini; Francesco Franchi; Jung Rae Cho; Christopher Degroat; Mona Bhatti; Elisabetta Ferrante; Ronakkumar Patel; Andrew Darlington; Antonio Tello-Montoliu; Bhaloo Desai; Joséluis Ferreiro; Ana Muniz-Lozano; Martin M Zenni; Luis A Guzman; Theodore A Bass; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2014-01-07       Impact factor: 4.132

Review 4.  Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes.

Authors:  Anusha Ande; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-07-04       Impact factor: 4.481

5.  CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor.

Authors:  Junjie Zhu; Pengcheng Wang; Feng Li; Jie Lu; Amina I Shehu; Wen Xie; Deborah McMahon; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2018-10-17       Impact factor: 5.858

6.  Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract.

Authors:  Marc Le Vee; Elodie Jouan; Bruno Stieger; Valérie Lecureur; Olivier Fardel
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

7.  Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients.

Authors:  Jianping Zhang; Siobhán Hayes; Brian M Sadler; Ilisse Minto; Julie Brandt; Steve Piscitelli; Sherene Min; Ivy H Song
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

Review 8.  Pharmacological approaches to the challenge of treatment-resistant depression.

Authors:  Dawn F Ionescu; Jerrold F Rosenbaum; Jonathan E Alpert
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

9.  In vitro analysis of factors influencing CYP1A2 expression as potential determinants of interindividual variation.

Authors:  ChengHui Xie; Marta Pogribna; Beverly Word; Lascelles Lyn-Cook; Beverly D Lyn-Cook; George J Hammons
Journal:  Pharmacol Res Perspect       Date:  2017-03-02

10.  High On-Treatment Platelet Reactivity in Danish Hyper-Acute Ischaemic Stroke Patients.

Authors:  Charlotte L Rath; Niklas Rye Jørgensen; Troels Wienecke
Journal:  Front Neurol       Date:  2018-08-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.